| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3934480 | European Urology Supplements | 2008 | 8 Pages |
Abstract
Urinary cytology and TURB (preferably under the guidance of fluorescence cystoscopy if carcinoma in situ is suspected) are the mainstays of bladder cancer diagnosis and staging. The likelihood of recurrence or progression can be assessed using a tool developed by the EORTC that is based on common prognostic factors. Patients with disease progression can be offered cystectomy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Willem Oosterlinck, Fred Witjes, Richard Sylvester,